⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27905688 | 1.00 | — | — | |
| SCHEMBL4942063 | 0.84 | ACE (0.32) | — | |
| SCHEMBL5481124 | 0.84 | ACE (0.32) | — | |
| SCHEMBL3158026 | 0.78 | DPP4 (0.37) | — | |
| SCHEMBL28039168 | 0.78 | DPP4 (0.37) | — | |
| SCHEMBL28039166 | 0.78 | DPP4 (0.37) | — | |
| SCHEMBL22648657 | 0.77 | MMP2 (0.41) | — | |
| SCHEMBL201027 | 0.77 | MMP2 (0.41) | — | |
| SCHEMBL239567 | 0.76 | PTPN1 (0.36) | — | |
| SCHEMBL4942698 | 0.74 | SMN1; SMN2 (0.49) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2678334-A1 | ANTI-VIRAL COMPOUNDS | Abbvie Inc. (US) | 2014-01-01 | — | — | EP | disclosed |
| EP-2627651-A1 | ANTI-VIRAL COMPOUNDS | Abbvie Inc. (US) | 2013-08-21 | — | — | EP | disclosed |
| WO-2012116257-A1 | ANTI-VIRAL COMPOUNDS | ABBVIE INC. (US) | 2012-08-30 | — | — | WO | disclosed |
| WO-2012051361-A1 | ANTI-VIRAL COMPOUNDS | ABBOTT LABORATORIES (US) | 2012-04-19 | — | — | WO | disclosed |